Endoscopy Devices Market to Reach US$ 62.7 Billion by 2032 at 7.3% CAGR - North America Leads with 42% Share | Olympus, Boston Scientific, Fujifilm

The Global Endoscopy Devices Market reached US$ 36.4 billion in 2024 and is projected to reach US$ 62.7 billion by 2032, growing at a CAGR of 7.3% during the forecast period 2025-2032. The market is expanding steadily due to the increasing prevalence of gastrointestinal and respiratory disorders, rising demand for minimally invasive surgeries, and growing adoption of advanced endoscopic technologies in hospitals and clinics worldwide.

Endoscopy devices include flexible and rigid endoscopes, video endoscopes, and associated accessories used for diagnostic and therapeutic procedures. Market growth is driven by technological advancements such as high-definition imaging, 3D visualization, disposable endoscopes, and integration with AI for enhanced diagnostics. Increasing awareness of early disease detection, rising surgical procedures, and expanding healthcare infrastructure in emerging economies are expected to further support the global endoscopy devices market growth during the forecast period.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/endoscopy-devices-market?sai-v

The Endoscopy Devices Market is the sector that develops and supplies medical instruments and technologies used to visualize, diagnose, and treat conditions within internal organs and cavities.

Key Developments
✅ December 2025: Hospitals and specialty clinics increased adoption of advanced endoscopy devices with high-definition imaging and AI-assisted lesion detection to improve diagnostic accuracy.

✅ October 2025: Manufacturers launched next-generation flexible and disposable endoscopes to reduce infection risks and support minimally invasive procedures.

✅ August 2025: Rising prevalence of gastrointestinal disorders and cancer screening initiatives drove higher demand for endoscopy procedures and devices.

✅ June 2025: Integration of 3D imaging, augmented reality, and real-time navigation tools enhanced procedural precision and operator training for endoscopic interventions.

✅ March 2025: Research and development focused on novel endoscopic tools for therapeutic interventions, including tissue resection, ablation, and targeted drug delivery.

Mergers & Acquisitions
✅ December 2025: A leading medical device manufacturer acquired an endoscopy technology startup to expand its minimally invasive surgical solutions portfolio.

✅ October 2025: Strategic partnerships were formed between endoscopy device companies and hospital networks to deploy AI-enabled diagnostic systems and training programs.

✅ August 2025: Endoscopy device firms collaborated with imaging technology providers to integrate advanced visualization and AI-assisted detection into new devices.

✅ June 2025: Regional manufacturers expanded production capabilities through joint ventures and facility upgrades to meet growing procedural demand.

✅ March 2025: Industry players entered research collaborations with academic hospitals to accelerate development of therapeutic and diagnostic endoscopy innovations.

Key Players
Olympus | Boston Scientific | Fujifilm | Cook Medical | Medtronic | Arthrex | Conmed | Johnson & Johnson

Key Highlights
Olympus - 18.4%: Leads the market with advanced endoscopic systems, imaging technologies, and strong adoption in minimally invasive surgical procedures.

Boston Scientific - 16.7%: Driven by innovative medical devices for cardiovascular, urology, and endoscopy procedures with global clinical adoption.

Fujifilm - 14.2%: Provides high-resolution imaging systems, endoscopic solutions, and integrated surgical support technologies.

Cook Medical - 12.8%: Specializes in minimally invasive devices, interventional tools, and catheter-based therapies.

Medtronic - 11.4%: Known for cardiovascular, surgical, and neuromodulation devices with strong global presence.

Arthrex - 9.6%: Focuses on orthopedic and sports medicine devices, including arthroscopy and minimally invasive surgical solutions.

Conmed - 8.1%: Offers surgical instruments, visualization systems, and energy-based devices for minimally invasive procedures.

Johnson & Johnson - 9.8%: Supports the market with integrated surgical solutions, endoscopic devices, and global distribution networks.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=endoscopy-devices-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
- Rising prevalence of gastrointestinal and respiratory disorders requiring endoscopic diagnosis.

- Growing demand for minimally invasive surgical procedures and diagnostics.

- Technological advancements in high-definition imaging, flexible endoscopes, and disposable devices.

- Increasing adoption of endoscopy in emerging economies due to expanding healthcare infrastructure.

- Rising awareness of early disease detection and preventive healthcare.

- Expansion of outpatient surgical centers and hospital endoscopy services.

- Growing healthcare expenditure and investments in advanced diagnostic equipment.

Industry Developments
- Launch of advanced high-definition and 4K endoscopy systems.

- Development of disposable and single-use endoscopes to reduce infection risk.

- Expansion of robotic-assisted and AI-integrated endoscopy solutions.

- Growing partnerships between device manufacturers and hospitals for training and service support.

- Introduction of flexible and ultra-thin endoscopes for enhanced patient comfort.

- Increasing investment in portable and mobile endoscopy systems for remote diagnostics.

- Integration of endoscopy systems with hospital information and imaging management platforms.

Regional Insights
North America - 42% share: "Driven by strong healthcare infrastructure, high adoption of advanced endoscopy technologies, and increasing prevalence of GI and respiratory diseases."

Europe - 30% share: "Supported by growing focus on minimally invasive procedures, skilled healthcare workforce, and technological advancements in imaging systems."

Asia Pacific - 24% share: "Fueled by rising healthcare access, expanding hospital networks, and increasing demand for early disease detection and outpatient procedures."

Latin America - 3% share: "Boosted by improving healthcare infrastructure, growing awareness of endoscopic procedures, and rising adoption of minimally invasive diagnostics."

Middle East & Africa - 1% share: "Driven by early-stage adoption of advanced diagnostic devices, improving healthcare facilities, and rising medical tourism."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/endoscopy-devices-market?sai-v

Key Segments

➥ By Product
Endoscopes: Core instruments used to visualize internal organs and cavities for diagnostic and surgical purposes.

Endoscopic Visualization Equipment: Imaging systems, monitors, cameras, and light sources that enhance endoscopic procedures.

Accessories: Supporting tools such as biopsy forceps, snares, insufflators, and cleaning/sterilization kits for endoscopic applications.

➥ By Type
Rigid Endoscopes: Non-flexible instruments offering high-resolution imaging for procedures requiring precise control and stability.

Flexible Endoscopes: Bendable instruments allowing navigation through complex anatomical pathways for minimally invasive procedures.

Disposable Endoscopes: Single-use endoscopes designed to reduce infection risk and eliminate reprocessing requirements.

Capsule Endoscopes: Swallowable miniaturized devices providing non-invasive imaging of the gastrointestinal tract.

➥ By Applications
Arthroscopy: Visualization and treatment of joint cavities for orthopedic procedures.

Hysteroscopy: Examination and treatment of the uterine cavity.

Laparoscopy: Minimally invasive imaging of the abdominal or pelvic cavity for surgical and diagnostic purposes.

Urology: Procedures focused on the urinary tract, including kidney, bladder, and urethra examinations.

Sinus: Endoscopic procedures for diagnosis and treatment of nasal and sinus conditions.

Bronchoscopy: Imaging of the airways and lungs for respiratory diagnosis and interventions.

Gynaecology: Procedures involving female reproductive organs beyond hysteroscopy.

Gastroenterology: Visualization of the gastrointestinal tract for diagnosis and therapeutic interventions.

Cystoscopy: Examination of the bladder and urethra.

Sigmoidoscopy: Imaging of the sigmoid colon for diagnosis and monitoring of colorectal conditions.

Laryngoscopy: Visualization of the larynx and vocal cords for ENT diagnostics and treatments.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.